tradingkey.logo
搜尋

Collplant Biotechnologies Ltd

CLGN
添加自選
0.299USD
-0.001-0.30%
收盤 07-31 16:00美東報價延遲15分鐘
3.82M總市值
虧損本益比TTM

關於 Collplant Biotechnologies Ltd 公司

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Collplant Biotechnologies Ltd簡介

公司代碼CLGN
公司名稱Collplant Biotechnologies Ltd
上市日期Sep 01, 1993
CEORotem (Eran)
員工數量57
證券類型Ordinary Share
年結日Sep 01
公司地址4 Oppenheimer Street
城市REHOVOT
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編7670104
電話972732325600
網址https://www.collplant.com
公司代碼CLGN
上市日期Sep 01, 1993
CEORotem (Eran)

Collplant Biotechnologies Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--

常見問題

Collplant Biotechnologies Ltd的前五大股東是誰?

Collplant Biotechnologies Ltd的前五大股東如下:Mr. Yehiel Tal

有多少機構持有Collplant Biotechnologies Ltd(CLGN)的股份?

截至2026Q1,共有35家機構持有Collplant Biotechnologies Ltd的股份,合計持有的股份價值約為1.89M,占公司總股份的13.14% 。與2025Q4相比,機構持股有所增加,增幅為-218892.00。

哪個業務部門對Collplant Biotechnologies Ltd的收入貢獻最大?

在2026Q1,Revenues from licensing agreement業務部門對Collplant Biotechnologies Ltd的收入貢獻最大,創收2.00M,占總收入的84.35% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有